Cellectis (CLLS) Notes Payables (2014 - 2016)
Cellectis' (CLLS) quarterly Notes Payables came in at $2.1 million in Q1 2016, down 0.68% quarter-over-quarter from $2.1 million in Q4 2015.
Cellectis (CLLS) Notes Payables (2014 - 2016) Analysis & Trends
Cellectis' Notes Payables history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2016.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $2.1 million in Q1 2016; TTM through Mar 2016 was $2.1 million, a N/A change from a year earlier, with the FY2015 full-year figure at $2.1 million, up 86.22% from the prior year.
- Notes Payables eased to $2.1 million in Q1 2016 per CLLS's latest filing, from $2.1 million in the prior quarter.
- Across five years, Notes Payables topped out at $3.4 million in Q2 2015 and bottomed at $1.1 million in Q4 2014.
- The 3-year median for Notes Payables is $2.1 million (2015), against an average of $2.4 million.
- Biggest YoY gain for Notes Payables was 95.45% in 2015; the steepest drop was 95.45% in 2015.
- Year by year, Notes Payables stood at $1.1 million in 2014, then jumped by 95.45% to $2.1 million in 2015, then slipped by 0.68% to $2.1 million in 2016.
- Per Business Quant, the three latest CLLS Notes Payables figures stand at $2.1 million (Q1 2016), $2.1 million (Q4 2015), and $3.3 million (Q3 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 2.09 Mn |
| Dec 31, 2015 | 2.11 Mn |
| Sep 30, 2015 | 3.32 Mn |
| Jun 30, 2015 | 3.35 Mn |
| Dec 31, 2014 | 1.08 Mn |